| 2026-06-04 |
13D/A |
AUPH / Aurinia Pharmaceuticals Inc. |
Tang Capital Management Llc |
13,044,106 |
10.00 |
6.66 |
| 2026-06-03 |
13D/A |
CITR / CitroTech Inc. |
Ralston Ted |
2,202,859 |
9.82 |
-87.54 |
| 2026-06-03 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
15,384,250 |
14.60 |
0.00 |
| 2026-06-02 |
13D/A |
IOBTQ / IO Biotech, Inc. |
Lundbeckfond Invest A/S |
21,851,920 |
27.40 |
|
| 2026-06-01 |
13D/A |
OTLK / Outlook Therapeutics, Inc. |
GMS Ventures & Investments |
37,580,638 |
22.90 |
29.41 |
| 2026-06-01 |
13D/A |
QTTB / Q32 Bio Inc. |
Orbimed Advisors Llc |
4,127,987 |
17.40 |
83.22 |
| 2026-06-01 |
13D |
DRMA / Dermata Therapeutics, Inc. |
Kyri K. Van Hoose |
384,352 |
9.00 |
|
| 2026-06-01 |
13D/A |
BIOX / Bioceres Crop Solutions Corp. |
Agriculture Investment Group Corp. |
4,399,443 |
6.89 |
-36.04 |
| 2026-06-01 |
13D/A |
CITR / CitroTech Inc. |
BoltRock Holdings LLC |
4,528,936 |
19.20 |
8.25 |
| 2026-05-29 |
13D/A |
INAB / IN8bio, Inc. |
Emily Fairbairn |
215,431 |
2.20 |
-70.62 |
| 2026-05-29 |
13D/A |
GRTX / Galera Therapeutics, Inc. |
Emerald Bioventures, LLC |
61,029,978 |
30.20 |
51.75 |
| 2026-05-28 |
13D/A |
QTTB / Q32 Bio Inc. |
Atlas Venture Fund X, L.P. |
864,261 |
3.60 |
0.00 |
| 2026-05-28 |
13D/A |
EL / The Estée Lauder Companies Inc. |
Lauder Aerin |
19,102,009 |
7.20 |
33.62 |
| 2026-05-28 |
13D/A |
RANI / Rani Therapeutics Holdings, Inc. |
Samsara BioCapital, L.P. |
11,322,961 |
9.90 |
14.58 |
| 2026-05-28 |
13D/A |
PHGE / BiomX Inc. |
Deerfield Private Design Fund V, L.P. |
889,928 |
8.09 |
-10.02 |
| 2026-05-27 |
13D/A |
ASMB / Assembly Biosciences, Inc. |
Gilead Sciences Inc |
4,977,089 |
25.10 |
292.21 |
| 2026-05-27 |
13D/A |
ALXO / ALX Oncology Holdings Inc. |
LSV Associates, LLC |
2,942,525 |
2.20 |
-0.24 |
| 2026-05-27 |
13D |
SDEV / Stablecoin Development Corporation |
Sky Frontier Foundation |
3,009,502 |
9.90 |
|
| 2026-05-26 |
13D/A |
KNSA / Kiniksa Pharmaceuticals International, plc |
Baker Bros. Advisors Lp |
3,253,341 |
7.00 |
3.25 |
| 2026-05-22 |
13D/A |
PAHC / Phibro Animal Health Corporation |
BFI Co., LLC |
19,552,186 |
48.20 |
-0.20 |
| 2026-05-21 |
13D |
UPC / Universe Pharmaceuticals INC |
Sununion Holding Group Ltd |
87,967 |
13.58 |
-99.30 |
| 2026-05-21 |
13D/A |
KALV / KalVista Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
1,249,165 |
2.30 |
-63.96 |
| 2026-05-20 |
13D/A |
IRD / Opus Genetics, Inc. |
Foundation Fighting Blindness Retinal Degeneration Fund |
3,792,171 |
4.66 |
-30.95 |
| 2026-05-19 |
13D/A |
SDEV / Stablecoin Development Corporation |
Framework Ventures IV L.P. |
32,715,086 |
46.40 |
47.68 |
| 2026-05-19 |
13D/A |
SDEV / Stablecoin Development Corporation |
R01 Fund LP |
37,548,058 |
50.30 |
42.92 |
| 2026-05-19 |
13D/A |
NKTX / Nkarta, Inc. |
New Enterprise Associates 15, L.P. |
3,568,781 |
4.90 |
0.00 |
| 2026-05-19 |
13D/A |
PUBC / PureBase Corporation |
Dockter A Scott |
109,481,634 |
39.40 |
144.58 |
| 2026-05-18 |
13D/A |
WHWK / Whitehawk Therapeutics, Inc. |
Acuta Capital Partners, Llc |
4,843,775 |
9.00 |
152.11 |
| 2026-05-18 |
13D/A |
XOMA / XOMA Royalty Corporation |
Biotechnology Value Fund L P |
7,593,303 |
43.30 |
193.14 |
| 2026-05-18 |
13D/A |
CASIF / CASI Pharmaceuticals, Inc. |
He Wei-Wu |
23,985,535 |
58.80 |
26.34 |
| 2026-05-18 |
13D/A |
SRZN / Surrozen, Inc. |
Column Group Iii Gp, Lp |
3,824,612 |
29.30 |
0.00 |
| 2026-05-15 |
13D/A |
LTRN / Lantern Pharma Inc. |
Bios Advisors Gp, Llc |
571,305 |
4.48 |
|
| 2026-05-15 |
13D/A |
NVAX / Novavax, Inc. |
Shah Capital Management |
14,841,000 |
9.03 |
-0.03 |
| 2026-05-14 |
13D/A |
ATRA / Atara Biotherapeutics, Inc. |
Redmile Group, LLC |
950,994 |
9.90 |
26.59 |
| 2026-05-14 |
13D/A |
WHWK / Whitehawk Therapeutics, Inc. |
Avoro Capital Advisors LLC |
18,292,675 |
19.99 |
53.53 |
| 2026-05-14 |
13D/A |
NAMS / NewAmsterdam Pharma Company N.V. |
BCLS Fund III Investments, LP |
2,059,896 |
1.76 |
-61.69 |
| 2026-05-14 |
13D/A |
HOWL / Werewolf Therapeutics, Inc. |
Ra Capital Management, L.p. |
6,116,140 |
12.60 |
-8.46 |
| 2026-05-13 |
13D/A |
ARMP / Armata Pharmaceuticals, Inc. |
Innoviva, Inc. |
55,467,459 |
82.70 |
0.00 |
| 2026-05-13 |
13D/A |
VRDN / Viridian Therapeutics, Inc. |
Fairmount Funds Management LLC |
17,201,800 |
14.04 |
7.34 |
| 2026-05-12 |
13D/A |
HOWL / Werewolf Therapeutics, Inc. |
MPM BioVentures 2014, L.P. |
1,826,646 |
3.80 |
-29.97 |
| 2026-05-12 |
13D/A |
FR:VLA / Valneva SE |
Bpifrance Participations SA |
19,074,653 |
9.30 |
|
| 2026-05-11 |
13D/A |
ATRA / Atara Biotherapeutics, Inc. |
Panacea Innovation Ltd |
1,318,894 |
16.10 |
139.80 |
| 2026-05-11 |
13D/A |
AURA / Aura Biosciences, Inc. |
Matrix Capital Management Company, LP |
0 |
0.00 |
-100.00 |
| 2026-05-08 |
13D/A |
LXRX / Lexicon Pharmaceuticals, Inc. |
Invus Global Management, LLC |
175,156,062 |
39.40 |
|
| 2026-05-07 |
13D/A |
LONA / LeonaBio, Inc. |
Perceptive Advisors Llc |
1,882,370 |
19.99 |
1.24 |
| 2026-05-07 |
13D/A |
TRVI / Trevi Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
15,074,080 |
10.50 |
0.00 |
| 2026-05-06 |
13D/A |
QTTB / Q32 Bio Inc. |
Orbimed Advisors Llc |
2,252,987 |
13.30 |
0.00 |
| 2026-05-06 |
13D/A |
RLYB / Rallybio Corporation |
5AM Ventures V, L.P. |
0 |
0.00 |
-100.00 |
| 2026-05-05 |
13D/A |
HOWL / Werewolf Therapeutics, Inc. |
MPM BioVentures 2014, L.P. |
2,608,501 |
5.40 |
-22.57 |
| 2026-05-05 |
13D/A |
TRAW / Traws Pharma, Inc. |
Orbimed Advisors Llc |
1,876,198 |
11.90 |
146.60 |